Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.41 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PTAFR | P25105 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyne SCHEMBL4043028 | 0.98 | ACHE (0.50) | ACHECYP3A4MAPTCA9PTGS2 | |
| SCHEMBL12435004 | 0.87 | ACHE (0.45) | ACHECYP3A4MAPTCA9PTGS2 | |
| SCHEMBL31004967 | 0.87 | ACHE (0.40) | ACHECYP3A4MAPTCA9PTGS2 | |
| SCHEMBL6196885 | 0.86 | TSHR (0.46) | ACHECYP3A4MAPTCA9HPGD | |
| SCHEMBL29254171 | 0.81 | HTR2A (0.51) | MAPTPTGS2HTR2AHTR2CHTR2B | |
| SCHEMBL29254183 | 0.80 | ACHE (0.33) | ACHECYP3A4MAPTCA9PTGS2 | |
| SCHEMBL29254175 | 0.78 | HTR2A (0.49) | MAPTPTGS2HTR2AHTR2CHTR2B | |
| SCHEMBL31004962 | 0.78 | HTR2A (0.49) | MAPTPTGS2HTR2AHTR2CHTR2B | |
| SCHEMBL29254234 | 0.77 | EGFR (0.37) | ACHECYP3A4MAPTCA9PTGS2 | |
| SCHEMBL10423619 | 0.76 | ACHE (0.52) | ACHECYP3A4MAPTCA9PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103896745-A | Anticancer drug Combretastatin A4 analogue and preparation method thereof | NANJING UNIVERSITY OF TECHNOLOGY | 2014-07-02 | — | — | CN | claimed |
| EP-1630165-B1 | [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF | NIPPON KAYAKU KK (JP) | 2010-03-31 | — | — | EP | claimed |
| EP-0341213-B1 | 5-Aryl-substituted-2,3-dihydro-imidazo [1,2-a]furo[3,2-c]- or thieno[2,3-c]pyridines | SANDOZ AG (CH) | 1995-02-22 | — | — | EP | claimed |
| EP-0607077-A1 | Salts of 4-pyrimidinone derivatives, their preparation and their application in therapy | SYNTHELABO (FR) | 1994-07-20 | — | — | EP | claimed |
| EP-0191025-B1 | N-6 AND 5'-N SUBSTITUTED CARBOXAMIDOADENOSINE DERIVATIVES AS CARDIAC VASODILATORS AND ANTIHYPERTENSIVE AGENTS, AND PROCESS FOR MAKING SAID COMPOUNDS | Whitby Research Incorporated (US) | 1990-03-07 | — | — | EP | claimed |
| CN-120166988-A | Compound and method for producing same | 学校法人帝京大学 | 2025-06-17 | — | — | CN | disclosed |
| CN-116535304-B | Erianin analogue, and synthetic method and application thereof | 中国科学院成都生物研究所 | 2024-07-19 | — | — | CN | disclosed |
| CN-118324684-A | Antitumor compound and pharmaceutical composition and application thereof | 上海中医药大学 | 2024-07-12 | — | — | CN | disclosed |
| CN-116589418-A | 2-triazoloethane-1-one/alcohol HSP90/HIF-1 inhibitor and application thereof | 大连理工大学 | 2023-08-15 | — | — | CN | disclosed |
| CN-116535304-A | Erianin analogue, and synthetic method and application thereof | 中国科学院成都生物研究所 | 2023-08-04 | — | — | CN | disclosed |
| CN-110357880-A | The chiral fluorescent chemicals and the preparation method and application thereof with circular polarised luminescence property based on folded formation | 北京师范大学 | 2019-10-22 | — | — | CN | disclosed |
| CN-107641088-B | A kind of synthetic method of benzonitrile class compound | 浙江工业大学 | 2019-05-31 | — | — | CN | disclosed |
| EP-1400515-A1 | CYCLIC DIAMINE COMPOUND HAVING FIVE-MEMBERED CYCLIC GROUP | Kowa Co., Ltd. (JP) | 2004-03-24 | — | — | EP | disclosed |
| US-6509329-B1 | Inhibitory effects on both cell adhesion and cell infiltration and is useful as a medicine for prevention or treatment of diseases such as allergy, asthma, rheumatism, arteriosclerosis and inflammation | KOWA CO., LTD. (JP) | 2003-01-21 | — | — | US | disclosed |
| US-6472386-B1 | Cyclic diamine compound with 5-membered ring groups | KOWA CO., LTD. (JP) | 2002-10-29 | — | — | US | disclosed |
| EP-0607077-A1 | Salts of 4-pyrimidinone derivatives, their preparation and their application in therapy | SYNTHELABO (FR) | 1994-07-20 | — | — | EP | disclosed |
| US-4959391-A | LIPOXYGENASE INHIBITORS, LEUKOTRIENE DISEASES | GRUENENTHAL GMBH (DE) | 1990-09-25 | — | — | US | disclosed |
| EP-0202529-B1 | PHENOL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THE PREPARATION OF THESE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS | Grünenthal GmbH (DE) | 1989-12-13 | — | — | EP | disclosed |
| US-4760087-A | 5-lipoxygenase inhibitor | GRUENENTHAL GMBH (DE) | 1988-07-26 | — | — | US | disclosed |
| EP-0202529-A2 | Phenol derivatives, pharmaceutical compositions containing them and processes for the preparation of these compounds and pharmaceutical compositions | Grünenthal GmbH (DE) | 1986-11-26 | — | — | EP | disclosed |